In Phase A, participants will obtain distinctive doses and schedules of oral ABBV-744 tablet to discover safe dosing regimen. More participants is going to be enrolled on the determined monotherapy dosign program. In Phase B, contributors will receive oral ruxolitinib and ABBV-744 is going to be given as "include-on" therapy. https://claytoneseqb.blogsvirals.com/31248129/5-easy-facts-about-is-abbv-744-effective-for-hematologic-cancers-described